Board meeting scheduled for May 08, 2026 to approve audited financial results for Q4 and FY ending March 31, 2026.
Agenda includes adoption of annual standalone and consolidated financial statements for FY2025-26.
Board to consider redemption of ₹50 crore Secured Rated Listed Redeemable NCDs Series C.